Blood Lead Screening Tests for Medicaid-Enrolled Children
Under the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit, Medicaid-enrolled children are required to receive blood lead screenings, followup services, and treatment for conditions identified through screenings. This work expands on previous OIG work in EPSDT screenings and will incorporate State health department data to supplement screening rates for Medicaid-enrolled children who may receive lead screenings in other settings. Additionally, this work will identify barriers to and opportunities for improving required lead screenings and boosting education and outreach for practitioners, parents, and caregivers.
|Announced or Revised||Agency||Title||Component||Report Number(s)||Expected Issue Date (FY)|
|May 2020||Centers for Medicare and Medicaid Services||Blood Lead Screening Tests for Medicaid-Enrolled Children||Office of Evaluation and Inspections||OEI-07-18-00371||2021|